CAS No – 114899-77-3

Status – DMF Ready

Product Description

Trabectedin selectively targets monocytes and tumor associated macrophages and downregulates the production of inflammatory mediators such as IL-6 and CCL2, which may underlie the strong association between chronic inflammation and cancer progression.